Skip to search formSkip to main contentSkip to account menu

valdecoxib

Known as: 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide, 4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide, valdecoxib [Chemical/Ingredient] 
A sulfonamide derivative and non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities. Valdecoxib… 
National Institutes of Health

Related topics

Related topics

10 relations

Narrower (1)

Bextra

Broader (3)

Cyclooxygenase 2 InhibitorsIsoxazolesSulfonamides
Degenerative polyarthritisDrug AllergyDysmenorrheaPregnancy

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Pharmacokinetics of intravenous and intramuscular parecoxib in healthy Beagles.
2011
2011
Defects in mouse nephrogenesis induced by selective and non‐selective cyclooxygenase‐2 inhibitors
BACKGROUND AND PURPOSE Deletion of the cyclooxygenase‐2 (COX‐2) gene causes impairment of kidney development, but the effect of… 
2010
2010
Best evidence topic - Cardiac general Does the use of non-steroidal anti-inflammatory drugs after cardiac surgery increase the risk of renal failure?
2009
2009
Prolonged opportunity for neuroprotection in experimental stroke with selective blockade of cyclooxygenase-2 activity
2009
2009
Reduction in Opioid-Related Adverse Events and Improvement in Function with Parecoxib followed by Valdecoxib Treatment after Non-Cardiac Surgery
AbstractBackground: Multimodal pain therapy including cyclo-oxygenase-2 inhibitors can result in optimal pain management with… 
2008
2008
Can drug removals involving cyclooxygenase-2 inhibitors be avoided? A plea for human pharmacology.
2006
2006
Do selective COX‐2 inhibitors increase the risk of cerebrovascular events? A meta‐analysis of randomized controlled trials
Objectives:  To evaluate the risk of cerebrovascular events (CVEs) associated with selective cyclooxygenase‐2 inhibitors (coxibs… 
2005
2005
Meta‐analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase‐2‐specific inhibitor, compared with nonspecific nonsteroidal anti‐inflammatory drugs among patients with…
Aim : To compare the incidence of abdominal pain, dyspepsia and/or nausea associated with valdecoxib, nonspecific nonsteroidal… 
2004
2004
Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
2004
2004
The analgesic effects that underlie patient satisfaction with treatment
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)